ENTITY
SMARTSCORE: 2.8/5
Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB (SOBI SS)

6
Analysis
Health CareSweden
Swedish Orphan Biovitrum AB (SOBI) operates as a bio-pharmaceutical and bio-technology company. The Company develops therapies and drugs for the treatment of haemophilia, inflammation, and genetic diseases. SOBI serves clients worldwide.
more
18 Jun 2025 12:41

Swedish Orphan Biovitrum AB: Strategic Launches

Swedish Orphan Biovitrum AB (Sobi), a pharmaceutical company specializing in the treatment of rare diseases, presented its Q1 2025 results.

Logo
197 Views
Share
30 Aug 2024 16:53

Expecting Downside Ahead; Stick With Defensives; Downgrading Taiwan to Market Weight; Risk-Off Signs

Expecting Downside Ahead $ACWI $SPX; Stick With Defensive Sectors; Downgrading Taiwan $EWT $TSM to Market Weight; Global Discretionary vs. Staples...

Logo
425 Views
Share
05 Jan 2024 19:50

Buys Within Global Energy, Health Care, and Utilities; Bullish Outlook Intact on Global Equities

Seeing a clear shift into value and defensives, and we recommend adding exposure to these areas globally. Constructive if supports hold: $98-99 on...

Logo
535 Views
Share
12 Sep 2021 19:22

Advent & GIC/SOBI: Awaiting a Sweetened Offer

Median implied valuation across multiples is SEK 246.71/share, c. 5% above offer price. I believe that the offer from the bidding consortium may be...

Share
bullishMSCI ACWI Index
19 Feb 2020 23:53

Global Equity Strategy: Buy the Dips

Despite recent weakness across global markets, our weight of the evidence approach continues to lead us to the same conclusions as we posited in...

Logo
470 Views
Share
x